This allocation represents a reduction of around US$3.6 million compared to 2025, when PIISAH received US$26 million in funding.
The investment will go towards strengthening genetics, enhancing feed and fodder production, expanding cold-chain infrastructure, and supporting farmer organisations.
Hy-D® can now be used commercially in aquaculture across the European Union, effective from December 31, 2025.
Fragmented regulatory systems, coupled with challenges such as inadequate cold-chain infrastructure, continue to hinder veterinary solutions.
The government finds this situation concerning as inadequate nutrition for animals threatens incomes, food security, and community stability.
FMD is one of the most persistent threats to livestock production in Eastern Africa, made worse by the extensive mobility of pastoral herds and porous borders.
This ruling restores predictabilityamid rising feed expenses, outbreaks of avian influenza, and supply chain disruptions.
Meanwhile, research shows that the global market size for animal antibiotics is likely to more than triple in the next decade.
Since 2021, highly pathogenic avian influenza H5 has caused unprecedented losses worldwide.
The 2026 budget increase is intended to support initiatives to expand domestic production and reduce dependency on imports.